PHARMExcel celebrates 15 years’ CRO impact in clinical trials for NHS, investigator and biotech research

Today marks the 15th anniversary of PHARMExcel, an award-winning specialist Contract Research Organisation (CRO) dedicated to delivering high-quality, tailored clinical research services for academic and commercial clinical trials. Over the past 15 years, PHARMExcel has grown from a small, ambitious team into a trusted partner to the NHS, global pharmaceutical companies, emerging biotechs, and renowned healthcare bodies such as Moorfields Eye Hospital, UK-CLIF and Rare Disease Research Partners.

Through exceptional services and dedication, PHARMExcel has consistently upheld its mission of improving patient outcomes and making a difference.

Reflecting on this milestone, Yvanne Enever, CEO of PHARMExcel, said:

“Fifteen years ago, we set out to make a real difference in clinical research by prioritising quality, integrity, and flexibility. Today, we celebrate not just our achievements but the impact we’ve made for our NHS, academic and commercial clients, and, ultimately, for patients. Looking ahead, we are excited to deepen our collaborations and play an even bigger role in shaping the future of global healthcare.”

1. From NHS Nurse to CEO – Yvanne Enever establishes PHARMExcel
2. Awarded international ISO 9001 quality management standard. [More]
3. New partnership with the Experimental Cancer Medicine Centre (ECMC) to deliver revolutionary radiation therapy in phase I clinical trial TRALA. [More]
4. Launched quality management system, DOT compliance. [More]
5. Selected CRO for the world’s first COVID-19 booster trial. [More]
6. COV-Boost academic paper published in the Journal of Infection. [More]
7. Awarded Top 5 CRO in UK [More]
8. Best Business of the Year Honours (Hertfordshire Chamber of Commerce) [More]
9. Businesswoman of the Year for PHARMExcel’s CEO, Yvanne Enever [More]
10. Achieved gold standard for Investors in People [More]
11. Hit patient recruitment milestone for rare autoimmune condition Behcet’s. [More]
12. Our ‘Hepatology Trials UK Review’ published in Frontline Gastroenterology. [More]
13. Recognised among Most Impactful CRO at OBN Life Sciences Awards. [More]
14. Honours at SCRIP Awards for Best CRO Specialist Provider. [More]
15. Over £3,000 raised by staff for Alzheimer’s disease-related charities. [More]

As PHARMExcel looks to the future, it aims to build on its role as the official CRO partner to the NHS and emerging global biotechs. This vision includes:

1. Accelerating clinical research programs for NHS Trusts and universities by filling resource gaps with specialist expertise such as safety monitoring and trial management.
2. Supporting the UK’s HealthTech Research Centres in conducting in-house trials and generating the high-quality evidence needed to showcase the benefits of medical device innovations.
3. Expanding PHARMExcl’s global focus on rare disease clinical research, ensuring that solutions for patients with unmet needs remain a top priority.
4. Offering tailored guidance to emerging biotechs at clinical trial stage, empowering them to succeed in their commercial pathway.

With a client-centric approach, PHARMExcel is committed to making an impact not just in the UK but across the global healthcare landscape. In a time when sponsors increasingly recognise the value of specialist CROs, PHARMExcel stands out with its flexible, tailored services—offering an alternative to larger, less agile providers.

“We are here to ensure that every client, no matter their size, receives the dedicated support they need to succeed,” added Yvanne Enever.

About PHARMExcel

PHARMExcel is an award-winning, full-service Contract Research Organisation (CRO) providing a flexible and innovative approach to clinical trial delivery. The company is recognised for its in-depth knowledge and experience of the clinical research environment, particularly in the UK, and has a network of regulatory and industry associates, allowing it to provide a global reach.

Media Contact
Katie Howe, Head of Marketing
E: [email protected]
T: +44 (0)20 3642 6654